Yoko Hasegawa

Biodegradable polyamino acid-based polycations as safe and effective gene carrier minimizing cumulative toxicity

Keiji Itaka, Takehiko Ishii, Yoko Hasegawa et al. · Biomaterials · 2010 · 206 citations

Pharmacy, Biotechnology, Molecular Pharmaceutics +16

CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity

Keiichi Sakakibara, Naoya Saito, Takuji Sato et al. · Blood · 2011 · 118 citations

Pharmacy, Medicinal Chemistry, Pharmacology +3

Polycation liposomes, a novel nonviral gene transfer system, constructed from cetylated polyethylenimine

Y. Yamazaki, Mamoru Nango, Mituso Matsuura et al. · Gene Therapy · 2000 · 115 citations

Pharmacy, Bioengineering, Biotechnology +14

Fatty Acid Synthase Is a Key Target in Multiple Essential Tumor Functions of Prostate Cancer: Uptake of Radiolabeled Acetate as a Predictor of the Targeted Therapy Outcome

Yukie Yoshii, Takako Furukawa, Nobuyuki Oyama et al. · PLoS ONE · 2013 · 101 citations · Full text

Medicine, Oncology, Pharmacology +17

Influence of Human Jaw Movement on Cerebral Blood Flow

Yoko Hasegawa, Takahiro Ono, Kazuhiro Hori et al. · Journal of Dental Research · 2007 · 89 citations

Dentistry, Oral Biology, Motor Control +11